Keyphrases
Tumor Necrosis Factor-α
100%
NF-κB Pathway
100%
Ankylosing Spondylitis
100%
High Activity
100%
Interleukin-17 (IL-17)
100%
Interleukin-23 (IL-23)
100%
TLR1
30%
TNFRSF1A
30%
Confidence Interval
30%
Odds Ratio
30%
Polymorphism
30%
Gene Regulating
20%
Toll-like Receptor 4 (TLR4)
20%
Homozygous Variant
20%
Rs187238
20%
IL-23R
20%
Interleukin-18 (IL-18)
20%
Rs361525
20%
Inflammation
20%
Needs Validation
10%
DANBIO Registry
10%
Routine Care
10%
Candidate Gene Approach
10%
Risk Reduction
10%
Heterozygous Variant
10%
Rs2476601
10%
Functional Single nucleotide Polymorphism
10%
Heritability
10%
Bonferroni Correction
10%
Risk Loci
10%
Biologic Disease-modifying Antirheumatic Drugs
10%
PTPN22
10%
Susceptibility Genes
10%
Logistic Regression
10%
TNF-308
10%
Environmental Factors
10%
Denmark
10%
Biochemistry, Genetics and Molecular Biology
Tumor Necrosis Factor Alpha
100%
Tumor Necrosis Factor
100%
TLR 1
75%
TLR4
50%
Genotyping
25%
PTPN22
25%
Case-Control Study
25%
Single-Nucleotide Polymorphism
25%
Candidate Gene
25%
Immunology and Microbiology
Tumor Necrosis Factor Alpha
100%
Ankylosing Spondylitis
100%
Tumor Necrosis Factor
40%
TNFRSF1A
30%
TLR 1
30%
TLR4
20%
Heritability
10%
Single Nucleotide Polymorphism
10%
Disease-Modifying Antirheumatic Drug
10%